Gene Therapy Restores Hearing in 42 Deaf Children and Young Adults—Results Hold Strong After 2.5 Years
A groundbreaking gene therapy trial successfully restored hearing and speech perception in 42 patients with genetic deafness, with life-changing benefits lasting over two years. The AAV1-hOTOF treatment offers new hope for families affected by autosomal recessive hearing loss.